Two cases of unstable angina in patients treated with bevacizumab

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 7, 2010, Pages 1405-1408

  Okada, Yoshinobu ^a   Okura, Yuji ^a   Takii, Yasumasa ^a  

^a NIIGATA CANCER CENTER HOSPITAL   (Japan)

Author keywords

Bevacizumab; Colorectal cancer; Percutaneous coronary intervention; Unstable angina

Indexed keywords

BEVACIZUMAB;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; COLORECTAL CANCER; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; FAMILIAL HYPERLIPEMIA; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIVER METASTASIS; LUNG METASTASIS; MALE; PERCUTANEOUS CORONARY INTERVENTION; SMOKING; UNSTABLE ANGINA PECTORIS;

EID: 79961117697     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Saif MW and Mehra R: Incidence and management of bevacizumab-related toxicities in colorectal cancer. Expert Opin Drug Saf 5(4): 553-566, 2006. (Pubitemid 44468452)
2. Shord SS, Bressler LR, Tierney LA, et al: Understanding and managing the possible adverse effect associated with bevacizumab. Am J Health Syst Pharm 66(11): 999-1013, 2009.
3. Kabbinavar FF, Schulz J, McCleod M, et al: Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer results of a randomized phase II trial. J Clin Oncol 23(16): 3697-3705, 2005.
4. Scappaticci FA, Skillings JR, Holden SN, et al: Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 99(16): 1232-1239, 2007. (Pubitemid 47299901)
5. Pereg D and Lishner M: Bevacizumab treatment for cancer patients with cardiovascular disease: a double edged sword ? Eur Heart J 29(19): 2325-2326, 2008.
6. de Graaf JC, Banga JD, Moncada S, et al: Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85(16): 2284-2290, 1992.
7. Kilickap S, Abari H and Celik I: Bevacizumab, bleeding, thrombosis, and warfarin. J Clin Oncol 21(18): 3542, 2003.
8. Kimura T, Morimoto T, Nakagawa Y, et al: Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 119(7): 987-995, 2009.
9. Hambleton J, Skilling J, Kabbinavar F, et al: Safety of low-dose aspirin (ASA) in a pooled analysis of 3 randomized, controlled trials (RCTs) of bevacizumab (BV) with chemotherapy (CT) inpatients (pts) with metastatic colorectal cancer (mCRC). Proc ASCO 23(16S): abstr 3554, 2005.